Our findings from this admittedly small study are, nevertheless, so promising for newly diagnosed Type 1 diabetes patients that we are now absolutely focused on pursuing a larger study for a longer period of time, says Paresh Dandona, SUNY Distinguished Professor, former chief of the Division of Endocrinology in the Jacobs School of Medicine and Biomedical Sciences at UB, a physician with UBMD Internal Medicine and senior author on the paper
Upper-mid dose
In contrast, limited weight loss or persistent appetite should prompt assessment of medication exposure, dose escalation, gastrointestinal tolerability, adherence, treatment interruption, concomitant medications, dietary compensation, and behavioural drivers of eating, consistent with evidence that early response may help identify patients more likely to achieve clinically meaningful longer-term weight loss (93)
Payments for insulin and for drugs that require a prescription for its use How do I qualify for the medical expenses deduction
Diabetes Patients Also Struggle to Access GLP-1 Agonists | MedPage Today
Effect of local administration of insulin-like growth factor I combined with inside-out artery graft on peripheral nerve regeneration
